UB
MYGN icon

UMB Bank’s Myriad Genetics MYGN Stock Holding History

UMB Bank’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Buy
+57,000
New +$259K ﹤0.01% 585
2026
Q1 		– Sell
-651
Closed -$4K – 2334
2025
Q4 		$4K Sell
651
-123
-16% -$892 ﹤0.01% 2066
2025
Q3 		$5.6K Buy
774
+704
+1,006% +$4.18K ﹤0.01% 1852
2025
Q2 		$372 Buy
+70
New +$413 ﹤0.01% 2087
2025
Q1 		– Sell
-254
Closed -$3.48K – 2146
2024
Q4 		$3.48K Buy
254
+47
+23% +$867 ﹤0.01% 1814
2024
Q3 		$5.67K Buy
207
+105
+103% +$2.84K ﹤0.01% 1686
2024
Q2 		$2.5K Buy
102
+66
+183% +$1.45K ﹤0.01% 1685
2024
Q1 		$768 Buy
+36
New +$774 ﹤0.01% 1860

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UMB Bank's MYGN Position: Q2 2026 in Review

UMB Bank opened a new position in Myriad Genetics (MYGN) in Q2 2026: 57,000 shares worth $325K. The stake represents ﹤0.01% of the portfolio and ranks #585 among its holdings. This is a return to the name: UMB Bank previously reported a position in MYGN as recently as Q4 2025.

UMB Bank first reported a position in MYGN in Q1 2024 and has held it in 8 quarters since. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • UMB Bank held 57,000 shares of Myriad Genetics worth $325K as of Q2 2026.
  • Myriad Genetics was a new UMB Bank position in Q2 2026.
  • Myriad Genetics made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #585 holding.
  • UMB Bank first reported a position in Myriad Genetics in Q1 2024 and has held it in 8 quarters since.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.